These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28042680)

  • 21. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
    Yuan CT; Cheng AL; Hou HA
    Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
    Mélard P; Idrissi Y; Andrique L; Poglio S; Prochazkova-Carlotti M; Berhouet S; Boucher C; Laharanne E; Chevret E; Pham-Ledard A; De Souza Góes AC; Guyonnet-Duperat V; Bibeyran A; Moreau-Gaudry F; Vergier B; Beylot-Barry M; Merlio JP; Cappellen D
    Oncotarget; 2016 Oct; 7(42):68734-68748. PubMed ID: 27626696
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Ketterling RP; Bedroske PP; Luoma IM; Sattler CA; Boddicker RL; Bennani NN; Nørgaard P; Møller MB; Steiniche T; d'Amore F; Feldman AL
    Blood; 2017 Jul; 130(4):554-557. PubMed ID: 28522440
    [No Abstract]   [Full Text] [Related]  

  • 24. Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
    Nieto-Benito LM; Parra-Blanco V; Gómez-Navarro Y; Menárguez-Palanca J; Pulido-Pérez A
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e670-e672. PubMed ID: 34014587
    [No Abstract]   [Full Text] [Related]  

  • 25. IRF4/DUSP22-positive anaplastic large cell lymphoma arising in the setting of chronic olecranon bursitis.
    Ku A; Alobeid B
    Blood; 2023 Jun; 141(23):2912. PubMed ID: 37289474
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
    Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
    Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
    Xing X; Flotte TJ; Law ME; Blahnik AJ; Chng WJ; Huang G; Knudson RA; Ketterling RP; Porcher JC; Ansell SM; Sidhu J; Dogan A; Feldman AL
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):580-9. PubMed ID: 25390351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
    Bisig B; Cairoli A; Gaide O; Somja J; Bregnard C; Gaulard P; Xerri L; Lefort K; Missiaglia E; Gilliet M; Hohl D; Guenova E; de Leval L
    Virchows Arch; 2022 Oct; 481(4):653-657. PubMed ID: 35366115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients.
    Osakada A; Fujimoto M; Ueshima C; Kaku Y; Nishikori M; Inoue N; Takeuchi K; Haga H
    Pathol Int; 2023 Sep; 73(9):456-462. PubMed ID: 37530485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas.
    Runge JS; Novice ML; Briones N; Williams K; Lowe L; Boyer DF; Wilcox RA; Tejasvi T; Hristov AC
    J Cutan Pathol; 2022 Mar; 49(3):299-305. PubMed ID: 34699105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
    Fadl A; Oishi N; Shi M; Dasari S; Ansell SM; Ketterling RP; Feldman AL
    Hum Pathol; 2023 Nov; 141():6-14. PubMed ID: 37633531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
    Magaki S; Satyadev R; Chen Z; Yung KS; Vinters HV; Kinney MC; Said JW
    Brain Tumor Pathol; 2022 Jan; 39(1):25-34. PubMed ID: 34791573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
    Feldman AL; Dogan A; Smith DI; Law ME; Ansell SM; Johnson SH; Porcher JC; Ozsan N; Wieben ED; Eckloff BW; Vasmatzis G
    Blood; 2011 Jan; 117(3):915-9. PubMed ID: 21030553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous anaplastic large cell lymphoma with DUSP22-rearrangement presenting as a mimicker of mycosis fungoides: a case report and review of the literature.
    Pacheco JM; Forchhammer S; Otto F; Fend F; Frauenfeld L
    Leuk Lymphoma; 2024 Feb; 65(2):265-269. PubMed ID: 37933677
    [No Abstract]   [Full Text] [Related]  

  • 35. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.
    Khanlari M; Tang G; Hao S; Gong Y; Li S; Miranda RN; Lin P; Iyer S; Yin CC; Xie W; Vega F; Medeiros LJ; Xu J
    Br J Haematol; 2021 Jan; 192(1):e17-e21. PubMed ID: 33216956
    [No Abstract]   [Full Text] [Related]  

  • 37. ALK-positive anaplastic large cell lymphoma of the parotid gland.
    Yamamoto H; Shirasuchi H; Yao T; Uryu H; Oda Y; Tamiya S; Tsuneyoshi M
    Histopathology; 2003 Oct; 43(4):397-8. PubMed ID: 14511260
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.
    Karai LJ; Kadin ME; Hsi ED; Sluzevich JC; Ketterling RP; Knudson RA; Feldman AL
    Am J Surg Pathol; 2013 Aug; 37(8):1173-81. PubMed ID: 23648461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22.
    Csikesz CR; Knudson RA; Greipp PT; Feldman AL; Kadin M
    J Invest Dermatol; 2013 Jun; 133(6):1680-2. PubMed ID: 23337887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.